Intraday BUY SELL Signals
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
GINX vs NVS
GINX vs NVS Comparison
Open Charts GINX vs NVS
SGI Enhanced Global Income ETF
Price$29.73
Change-$0.14 (-0.47%)
Volume$6.68K
Net Assets78.07M
Novartis AG
Price$127.34
Change-$0.67 (-0.52%)
Volume$10.94K
Capitalization245.77B
GINX vs NVS Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GINX vs. NVS commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Hold and NVS is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
NVS: Fundamental Ratings
NVS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 13 | |
SMR RATING 1..100 | 29 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 44 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | NVS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 46% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 44% |
| MACD ODDS (%) | 2 days ago 84% | 2 days ago 47% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 42% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 38% |
| Advances ODDS (%) | 8 days ago 89% | 8 days ago 50% |
| Declines ODDS (%) | 2 days ago 62% | 6 days ago 44% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 43% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 34% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUFS | 22.05 | 0.05 | +0.23% |
| FT Vest Laddered Small Cap Moderate Buffer ETF | |||
| FLC | 17.38 | 0.03 | +0.17% |
| Flaherty & Crumrine Total Return Fund | |||
| PLDR | 36.01 | -0.31 | -0.86% |
| Putnam Sustainable Leaders ETF | |||
| VONG | 118.55 | -1.54 | -1.28% |
| Vanguard Russell 1000 Growth ETF | |||
| AWAY | 20.54 | -0.32 | -1.53% |
| Amplify Travel Tech ETF | |||
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and FMS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and FMS's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | -0.22% | ||
| FMS - GINX | 26% Poorly correlated | -0.30% | ||
| SAN - GINX | 25% Poorly correlated | -2.21% | ||
| GSK - GINX | 25% Poorly correlated | -0.34% | ||
| NVS - GINX | 24% Poorly correlated | -2.69% | ||
| SONY - GINX | 23% Poorly correlated | -1.44% | ||
More | ||||
NVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y